GRx HiCort 25 Suppositories recalled over labeling errors
- Recall date
- October 27, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Geritrex Corp recalls GRx HiCort 25 (hydrocortisone acetate 25 mg) Suppositories, 12-count box, Rx only, Distributed by Geritrex Corporation…
- Recall number
- D-0392-2016
- FDA classification
- Class II
- Brand / firm
- Geritrex Corp
- Sold / distributed
- Nationwide
Why it was recalled
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
GRx HiCort 25 (hydrocortisone acetate 25 mg) Suppositories, 12-count box, Rx only, Distributed by Geritrex Corporation Mount Vernon, NY 10550, NDC 54162-015-12
Get recall alerts
Free email alert whenever Geritrex Corp has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Geritrex Corp